Molecular Evolution of Human Immunodeficiency Virus env in Humans and Monkeys: Similar Patterns Occur during Natural Disease Progression or Rapid Virus Passage
Open Access
- 15 May 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 76 (10) , 5278-5284
- https://doi.org/10.1128/jvi.76.10.5278-5284.2002
Abstract
Neonatal rhesus macaque 95-3 was inoculated with nonpassaged simian-human immunodeficiency virus strain SHIV-vpu + , which encodes env of the laboratory-adapted human immunodeficiency virus (HIV) strain IIIB and is considered nonpathogenic. CD4 + T-cell counts dropped to + neutralizing antibody titers and still used CXCR4 but, in contrast to parental SHIV-vpu + , productively infected macrophages and resisted neutralization. Sequence analysis revealed three new potential glycosylation sites in gp120; another two were lost. Strikingly similar mutations were detected in a laboratory worker who progressed to AIDS after accidental HIV-IIIB infection (T. Beaumont et al., J. Virol. 75:2246-2252, 2001), thus supporting the SHIV-vpu + /rhesus macaque system as a relevant model. Similar mutations were also described after rapid passage of chimeric viruses encoding IIIB env in rhesus and pig-tailed macaques (M. Cayabyab et al., J. Virol. 73:976-984, 1999; Z. Q. Liu et al., Virology 260:295-307, 1999; S. V. Narayan et al., Virology 256:54-63, 1999; R. Raghavan et al., Brain Pathol. 7:851-861, 1997; E. B. Stephens et al., Virology 231:313-321, 1997). Thus, HIV-IIIB env evolved similarly in three different species; this selection occurred in chronically infected individuals during disease progression as well as after rapid virus passage. We postulate that evolutionary pressure led to the outgrowth of more aggressive viral variants in all three species.Keywords
This publication has 40 references indexed in Scilit:
- Reversal of Human Immunodeficiency Virus Type 1 IIIB to a Neutralization-Resistant Phenotype in an Accidentally Infected Laboratory Worker with a Progressive Clinical CourseJournal of Virology, 2001
- Immunization with Recombinant Canarypox Vectors Expressing Membrane-Anchored Glycoprotein 120 Followed by Glycoprotein 160 Boosting Fails to Generate Antibodies That Neutralize R5 Primary Isolates of Human Immunodeficiency Virus Type 1AIDS Research and Human Retroviruses, 2000
- Characterization of Immune Escape Viruses from a Macaque Immunized with Live-Virus Vaccine and Challenged with Pathogenic SHIVKU-1AIDS Research and Human Retroviruses, 2000
- Sensitive and Robust One-Tube Real-Time Reverse Transcriptase-Polymerase Chain Reaction to Quantify SIV RNA Load: Comparison of One- versus Two-Enzyme SystemsAIDS Research and Human Retroviruses, 2000
- Viremia and AIDS in Rhesus Macaques after Intramuscular Inoculation of Plasmid DNA Encoding Full-Length SIVmac239AIDS Research and Human Retroviruses, 1999
- Conserved N-linked oligosaccharides of the C-terminal portion of human immunodeficiency virus type 1 gp120 and viral susceptibility to neutralizing antibodiesArchiv für die gesamte Virusforschung, 1996
- Loss of antibody reactivity directed against the V3 domain of certain human immunodeficiency virus type 1 variants during disease progressionJournal of General Virology, 1996
- Utility of SHIV for Testing HIV-1 Vaccine Candidates in MacaquesJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Initial characterization of viral sequences from a SHIV‐inoculated pig‐tailed macaque that developed AIDSJournal of Medical Primatology, 1996
- Mucosal Infection of Neonatal Rhesus Monkeys with Cell-Free SIVAIDS Research and Human Retroviruses, 1994